SynthesisThe Australasian journal of dermatology2025
A Systematic Review of Cellulitis Guidelines: The Role of Non-Pharmacological Management in Preventing Recurrence.
Synthesis in The Australasian journal of dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Epithelial-Dermal Immune Memory: TrackingInternational journal of molecular sciences · 2026Review
- Article
- Multimorbidity and risk of infection in patients with rheumatoid arthritis: Population-based case-control study.Seminars in arthritis and rheumatism · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cellulitis is a common acute skin and soft tissue infection with high rates of recurrence. Historically, guidelines for care have focused on pharmacological management; however, emerging evidence supports the benefits of non-pharmacological approaches for risk mitigation and recurrence prevention. This review examined best practice guidelines for the management of cellulitis-for the inclusion of recommendations beyond antibiotics to prevent recurrence. A systematic search of seven databases was conducted, including the Guidelines International Network (GIN), the Agency for Healthcare Research and Quality and the Australian National Health and Medical Research Council clinical practice guidelines. Guidelines were included if they addressed lower limb cellulitis, were developed after 2000, published in English, appeared in a peer-reviewed journal and/or were endorsed by a health agency or government body, and contained recommendations for non-pharmacological management. The Appraisal of Guidelines for Research and Evaluation II (AGREE II) tool was used to assess guideline quality. Ten guidelines met the inclusion criteria. Recommendations for non-pharmacological management and recurrence prevention primarily addressed risk factors such as venous disease, oedema, tinea, skin barrier integrity and obesity. However, these recommendations were often brief and lacked actionable strategies for managing local risk factors effectively. Most guidelines scored poorly in the AGREE II assessment, particularly in rigour of development, despite performing well in scope, purpose and clarity. Furthermore, non-pharmacological strategies and recurrence prevention remain underdeveloped. Strengthening the evidence base and incorporating targeted prevention strategies will be essential to improving future guidelines, ultimately enhancing patient outcomes and reducing the burden on healthcare systems. Trial Registration: Registered with Open Science Framework OSF: osf-registrations-7wkvf-v1.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.